|
GOLGA2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.720300E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.284000E-02 |
| Normal-vs-Stage2 |
9.018400E-02 |
| Normal-vs-Stage3 |
6.919800E-03 |
| Normal-vs-Stage4 |
3.719900E-03 |
| Stage1-vs-Stage2 |
8.522200E-01 |
| Stage1-vs-Stage3 |
2.698800E-01 |
| Stage1-vs-Stage4 |
1.658230E-01 |
| Stage2-vs-Stage3 |
6.044000E-01 |
| Stage2-vs-Stage4 |
4.086400E-01 |
| Stage3-vs-Stage4 |
6.423600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.159700E-03 |
| Normal-vs-AfricanAmerican |
4.757400E-01 |
| Normal-vs-Asian |
1.144170E-01 |
| Caucasian-vs-AfricanAmerican |
2.081000E-01 |
| Caucasian-vs-Asian |
3.941200E-01 |
| AfricanAmerican-vs-Asian |
5.529200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.087500E-02 |
| Normal-vs-Female |
8.182500E-03 |
| Male-vs-Female |
9.341600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.204200E-02 |
| Normal-vs-Age(41-60Yrs) |
3.406400E-02 |
| Normal-vs-Age(61-80Yrs) |
4.773600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.116200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.049400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.887900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.598200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.427800E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.846400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.197800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.878190E-01 |
| Classical-VS-Follicular |
2.533200E-01 |
| Classical-VS-Other |
3.285800E-01 |
| Classical-VS-Normal |
4.485800E-02 |
| Tall-VS-Follicular |
6.890800E-01 |
| Tall-VS-Other |
7.450800E-01 |
| Tall-VS-Normal |
1.535610E-02 |
| Follicular-VS-Other |
4.598800E-01 |
| Follicular-VS-Normal |
2.340300E-02 |
| Other-VS-Normal |
9.261600E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.223800E-03 |
| Normal-vs-N1 |
1.895890E-02 |
| N0-vs-N1 |
9.978600E-01 |
|
|
